Form 4: Orchestra BioMed COO's Tax Withholding Share Transaction

Orchestra BioMed Holdings, Inc. Director and COO Darren Sherman reported a disposition of 40,340 shares for tax withholding related to RSU vesting.

Summary

• Darren Sherman, President and Chief Operating Officer, and a Director of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on September 3, 2025.
• The transaction involved the disposition of 40,340 shares of common stock at a price of $2.72 per share.
• This disposition was a withholding of shares by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs).
• No shares were sold in the open market as a result of this transaction.
• Following this transaction, Darren Sherman beneficially owns 886,497 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While shares were disposed, it was for a routine tax obligation related to RSU vesting, not an open market sale. The insider retains a substantial holding, which is generally viewed favorably.

Positives

• The transaction was for tax withholding purposes related to RSU vesting, not an open market sale by the insider.
• The insider continues to hold a significant number of shares (886,497), indicating continued alignment with shareholder interests.

Negatives

• A reduction in direct beneficial ownership by 40,340 shares, even if for tax purposes.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction is a routine tax-related disposition, not an open market sale, which may alleviate concerns about insider selling. The insider's continued significant holding aligns interests with shareholders.

Key Dates

Recommendation

This Form 4 filing reports a routine, non-discretionary disposition of shares by an insider for tax withholding purposes related to RSU vesting. It does not reflect a change in the insider's investment conviction or the company's fundamentals. The insider retains a substantial equity stake. Therefore, this specific filing alone does not warrant a change in investment recommendation; a 'hold' stance is appropriate pending further fundamental analysis.

Keywords

Orchestra BioMed Holdings, OBIO, Darren Sherman, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Beneficial Ownership